VijayPD Ceutical Reports H1 FY27 Financial Results and Full IPO Proceeds Utilization
Vijaypd Ceutical Ltd · Outcome · 15 Nov 2026, 12:12 am
VijayPD Ceutical Reports H1 FY27 Financial Results and Full IPO Proceeds Utilization VijayPD Ceutical reported consolidated revenue from operations of ₹10,521.11 lakhs for the half year ended 30th Sep'26, up 104.95% YoY from ₹5,133.40 lakhs. Net profit attributable to owners reached ₹335.66 lakhs, rising 38.97% YoY from ₹241.54 lakhs, with diluted EPS at ₹1.72. On a standalone basis, revenue stood at ₹7,367.48 lakhs with PAT of ₹236.93 lakhs. The company confirmed 100% utilization of its ₹1,925.00 lakhs IPO proceeds with nil deviation across capex, debt repayment, and general corporate purposes.
Original exchange filing (PDF)
More announcements from Vijaypd Ceutical Ltd
- Vijaypd Ceutical Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 14 Nov 2026
- Vijaypd Ceutical Limited has informed the Exchange regarding Outcome of Board Meeting held on October 26, 2026. · 27 Oct 2026
- Vijaypd Ceutical Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the 30th September, 2026 · 12 Oct 2026
- Vijaypd Ceutical Limited has informed the Exchange about Appointment of Investor Relations (IR) agency · 06 Oct 2026
- Vijaypd Ceutical Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results. · 02 Oct 2026
- Vijaypd Ceutical Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026 · 01 Oct 2026
- Vijaypd Ceutical Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Technical Business Collaboration with Acute Research Private Limited'. · 18 Sept 2026
